KING PHARMACEUTICALS (KG) P/B (2011 - 2026)
KING PHARMACEUTICALS (KG) P/B from Feb 28, 2011 to Jun 3, 2026. The TTM KING PHARMACEUTICALS (KG) P/B is 0.74. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of KING PHARMACEUTICALS (KG)
| Year | P/B | Change |
|---|---|---|
| 2026 | 0.74 | +19.47% |
| 2025 | 0.62 | -96.63% |
| 2011 | 18.35 | N/A |
Comparison KING PHARMACEUTICALS (KG) P/B with competitors
KING PHARMACEUTICALS (KG) P/B is 0.74.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| GLRE | Greenlight Capital Re Ltd - Class A | 0.73 | -0.99% |
| EG | Everest Group Ltd | 0.89 | +20.27% |
| RGA | Reinsurance Group Of America Inc | 1.04 | +41.53% |
| HG | Hamilton Insurance Group Ltd - Class B | 1.08 | +46.14% |
| SPNT | SiriusPoint Ltd | 1.09 | +47.63% |
| RNR | RenaissanceRe Holdings Ltd | 1.11 | +50.34% |
| OXBR | Oxbridge Re Holdings Ltd | 1.22 | +64.97% |